U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study
In October 2014, the Drug Enforcement Administration in the U.S. reclassified hydrocodone combination products (HCPs) from Schedule III to Schedule II, initiating one of the most significant and controversial regulatory changes for opioids in recent national history. The aim of the present study was...
Main Authors: | Jordan R. Covvey, Andrea R. Pfalzgraf, Peter P. Cohron |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | http://www.mdpi.com/2226-4787/3/3/129 |
Similar Items
-
Hydrocodone bitartrate
by: 982 SIRIM -
CONSIDERATIONS REGARDING THE DECLARATION OF ENFORCEMENT
by: Nicolae-Horia ȚIȚ
Published: (2015-09-01) -
Policing within a professional framework /
by: Cavanagh, Michael E., 1937-
Published: (2004) -
SOME CONSIDERATIONS REGARDING THE NOTION OF ENFORCEMENT ORDER
by: Nicolae-Horia ȚIȚ
Published: (2015-07-01) -
Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice
by: Woonyen Wong, et al.
Published: (2023-10-01)